Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pablo Bartolucci

Showing results (121-130 of 128) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 128 results.
American Journal of Respiratory and Critical Care Medicine|April 10, 2025
Comparison of Prophylactic and Therapeutic Doses of Anticoagulation for Acute Chest Syndrome in Sickle Cell Disease: The TASC Randomized Clinical TrialArmand Mekontso Dessap, Anoosha Habibi, Jean-Benoît Arlet, et al.
The New England Journal of Medicine|March 2, 2017
Gene Therapy in a Patient with Sickle Cell DiseaseJean-Antoine Ribeil, Salima Hacein-Bey-Abina, Emmanuel Payen, et al.
The Lancet. Haematology|July 14, 2023
Sickle cell disease landscape and challenges in the EU: the ERN-EuroBloodNet perspectiveMaría Del Mar Mañú Pereira, Raffaella Colombatti, Federico Alvarez, et al.
The Lancet. Haematology|December 7, 2024
Safety and efficacy of mitapivat in sickle cell disease (RISE UP): results from the phase 2 portion of a global, double-blind, randomised, placebo-controlled trialModupe Idowu, Lucas Otieno, Bogdan Dumitriu, et al.
Nature Communications|April 1, 2025
Severe inflammation and lineage skewing are associated with poor engraftment of engineered hematopoietic stem cells in patients with sickle cell diseaseSteicy Sobrino, Laure Joseph, Elisa Magrin, et al.
BMJ Open|September 18, 2025
High flow oxygen for vaso-occlusive crisis: a multicentre, prospective, randomised, multi-arm, multi-stage clinical trial (OSONE)Armand Mekontso Dessap, Anoosha Habibi, Constance Guillaud, et al.
American Journal of Hematology|July 4, 2026
Undetectable Hydroxyurea Levels in the Majority of Sickle Cell Disease Patients, Especially in Young ChildrenSigrid van der Veen, Bart J Biemond, Marjon H Cnossen, et al.
Nature Medicine|January 25, 2022
Long-term outcomes of lentiviral gene therapy for the β-hemoglobinopathies: the HGB-205 trialElisa Magrin, Michaela Semeraro, Nicolas Hebert, et al.
Pageof 13

Showing results (121-130 of 128) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 128 results.
American Journal of Respiratory and Critical Care Medicine|April 10, 2025
Comparison of Prophylactic and Therapeutic Doses of Anticoagulation for Acute Chest Syndrome in Sickle Cell Disease: The TASC Randomized Clinical TrialArmand Mekontso Dessap, Anoosha Habibi, Jean-Benoît Arlet, et al.
The New England Journal of Medicine|March 2, 2017
Gene Therapy in a Patient with Sickle Cell DiseaseJean-Antoine Ribeil, Salima Hacein-Bey-Abina, Emmanuel Payen, et al.
The Lancet. Haematology|July 14, 2023
Sickle cell disease landscape and challenges in the EU: the ERN-EuroBloodNet perspectiveMaría Del Mar Mañú Pereira, Raffaella Colombatti, Federico Alvarez, et al.
The Lancet. Haematology|December 7, 2024
Safety and efficacy of mitapivat in sickle cell disease (RISE UP): results from the phase 2 portion of a global, double-blind, randomised, placebo-controlled trialModupe Idowu, Lucas Otieno, Bogdan Dumitriu, et al.
Nature Communications|April 1, 2025
Severe inflammation and lineage skewing are associated with poor engraftment of engineered hematopoietic stem cells in patients with sickle cell diseaseSteicy Sobrino, Laure Joseph, Elisa Magrin, et al.
BMJ Open|September 18, 2025
High flow oxygen for vaso-occlusive crisis: a multicentre, prospective, randomised, multi-arm, multi-stage clinical trial (OSONE)Armand Mekontso Dessap, Anoosha Habibi, Constance Guillaud, et al.
American Journal of Hematology|July 4, 2026
Undetectable Hydroxyurea Levels in the Majority of Sickle Cell Disease Patients, Especially in Young ChildrenSigrid van der Veen, Bart J Biemond, Marjon H Cnossen, et al.
Nature Medicine|January 25, 2022
Long-term outcomes of lentiviral gene therapy for the β-hemoglobinopathies: the HGB-205 trialElisa Magrin, Michaela Semeraro, Nicolas Hebert, et al.
Pageof 13